Search Results 941-950 of 19992 for anemia

  1. Oncology (Medical) - Doctors - Mayo Clinic

    ncer, Lung cancer, Multiple myeloma, Sickle cell anemia, Anemia, Prostate cancer, Sickle cell disease, Essential thrombocythemia. Show more areas of focus ...

  2. Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    Patients known to have one of the following concomitant genetic syndromes: Down syndrome, Bloom syndrome, ataxia-telangiectasia, Fanconi anemia, Kostmann ...

  3. A Study to Compare Three Chemotherapy Regimens for the Treatment of Patients with Newly- diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Uncontrolled AIHA (autoimmune hemolytic anemia) or ITP (idiopathic thrombocytopenia purpura).;; Requires or receiving anticoagulation with warfarin or ...

  4. Hematology - Clinical trials

    A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS). Jacksonville, Fla. The purpose of phase 2a is to ...

  5. For one patient, sharing her family medical history led to lifesaving care - Mayo Clinic News Network

    History of inherited conditions such as hemophilia, cystic fibrosis and sickle cell anemia; Cause and age of death; Birth defects; Family's ethnic background ...

  6. Hematology - Doctors - Mayo Clinic

    onic myelogenous leukemia, Aplastic anemia, Dyskeratosis congenita, Chronic ... anemia, Diamond-Blackfan anemia. Show more areas of focus for Mrinal S ...

  7. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

    coni anemia, Aplastic anemia, Chronic myelogenous leukemia, Myeloproliferative disorders, Chronic myelomonocytic leukemia, Dyskeratosis congenita, Diamond ...

  8. Tamsulosin (oral route) - Side effects & dosage - Mayo Clinic

    Tamsulosin is used to treat men who have symptoms of an enlarged prostate gland, which is also known as benign enlargement of the prostate (benign prostatic ...

  9. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis - Mayo Clinic

    Anemia with Hgb < 8.0 g/dL. Thrombocytopenia with platelet count < 100'000. Any other disease, metabolic dysfunction, physical examination finding, or ...

  10. Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes - Mayo Clinic

    ... anemia. Phase II: To investigate safety and efficacy of BI 836858 plus Best ... anemia without a deletion 5q cytogenetic abnormality. Participation ...